BMC Chemistry

Table 2 Determination of TCB and LVM in laboratory prepared mixtures and in Eradex Forte^® suspension by the proposed methods

From: Spectrum subtraction as a complementary method for six resolution techniques resolving overlapping spectra; application to multicomponent veterinary formulation with greenness and whiteness assessment

TCB:LVM ratio		TCB
		D⁰(304 nm)	D⁰(220 nm)			D¹(310 nm)	D¹(P _{228–216 nm})			DD¹(P_{230-220 nm})
		RS-SS	RS-SS	CM-SS	FC-SS	DS-SS	DS-SS	D¹ CM-SS	D¹ FC-SS
		R% ± S.D
2	3	98.49 ± 0.56	98.06 ± 0.05	98.01 ± 0.12	98.06 ± 0.06	101.33 ± 0.42	100.75 ± 0.41	100.80 ± 0.43	100.67 ± 0.53	99.93 ± 1.23
3	4	98.84 ± 0.33	98.18 ± 0.13	98.25 ± 0.14	98.26 ± 0.19	101.2 ± 0.34	100.28 ± 0.62	100.47 ± 0.43	99.57 ± 0.53	99.85 ± 1.29
1	1	99.86 ± 1.94	98.29 ± 1.99	100.58 ± 1.78	101.09 ± 1.94	101.18 ± 0.98	100.43 ± 0.69	100.99 ± 0.59	100.81 ± 0.49	99.99 ± 1.07
4.5	2.5	99.82 ± 0.17	98.61 ± 0.12	98.71 ± 0.21	98.54 ± 0.09	101.89 ± 0.35	100.41 ± 0.94	101.08 ± 0.96	101.53 ± 0.53	101.72 ± 0.72
*4	*2.5	98.57 ± 0.75	101.06 ± 1.97	100.3 ± 1.76	101.12 ± 1.94	100.31 ± 1.53	100.49 ± 0.62	101.81 ± 0.66	99.34 ± 0.53	99.53 ± 0.99
Eradex Forte^® Suspension
R% ± S.D
*4	*2.5	99.97 ± 1.42	100.19 ± 1.98	100.19 ± 1.99	100.26 ± 1.53	100.55 ± 1.99	100.53 ± 1.99	100.47 ± 1.98	100.58 ± 1.89	98.819 ± 0.827

TCB:LVM ratio		TCB		LVM
		CV	CNV	D⁰(214 nm) FC-SS			D¹(P_221 nm)			DD¹(P_219 nm)
				RS-SS	CM-SS		DS-SS	D¹ CM-SS	D¹ FC-SS
		R% ± S.D
2	3	98.49 ± 0.55	99.13 ± 0.56	99.05 ± 0.89	100.12 ± 1.014	99.92 ± 1.35	101.2 ± 0.69	101.91 ± 0.41	101.76 ± 0.62	100.46 ± 0.85
3	4	98.88 ± 0.09	99.49 ± 0.09	99.31 ± 0.96	98.85 ± 1.29	98.88 ± 1.40	99.03 ± 0.89	98.96 ± 0.67	99.06 ± 0.51	99.102 ± 1.29
1	1	98.93 ± 1.83	99.61 ± 1.83	101.7 ± 0.50	101.2 ± 0.59	101.46 ± 0.97	100.77 ± 0.77	100.51 ± 0.97	100.39 ± 1.39	100.14 ± 1.44
4.5	2.5	100.11 ± 0.42	100.74 ± 0.42	101.68 ± 1.44	101.99 ± 1.35	101.76 ± 1.46	101.8 ± 0.83	100.54 ± 0.54	100.18 ± 0.83	100.61 ± 1.07
*4	*2.5	100.47 ± 1.19	101.13 ± 1.19	101.93 ± 1.07	101.48 ± 1.26	101.44 ± 0.96	100 ± 1.95	100.72 ± 1.65	100.3 ± 1.65	100.21 ± 0.94
Eradex Forte^® Suspension
R% ± S.D
*4	*2.5	99.09 ± 1.21	99.78 ± 1.32	100.25 ± 1.96	99.39 ± 1.74	100.004 ± 1.53	100.62 ± 1.94	99.24 ± 1.83	99.45 ± 1.77	101.98 ± 0.39

*Dosage form ratio

Back to article page

ISSN: 2661-801X

Contact us

Submission enquiries: bmcchemistry@biomedcentral.com
General enquiries: ORSupport@springernature.com